Piclib 75MG Capsule (21’s) is a prescription medication that contains Palbociclib, a targeted therapy used primarily in the treatment of certain types of breast cancer. Specifically, it is indicated for patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer, often in combination with aromatase inhibitors or other hormonal therapies. Each capsule contains 75 mg of Palbociclib, which works by inhibiting specific proteins known as cyclin-dependent kinases (CDKs), particularly CDK4 and CDK6. This inhibition disrupts the cancer cell cycle, slowing down or stopping the growth of cancer cells. Piclib is typically prescribed for patients whose cancer has progressed after initial treatment, making it a crucial option in the management of advanced breast cancer. The drug is taken orally, and its effectiveness is enhanced when used in conjunction with other cancer therapies, providing a comprehensive approach to treatment.

Hertab 250MG Tablet (150’s) is a pharmaceutical product that contains Lapatinib as its active ingredient, with each tablet delivering a potent dose of 250 mg. This medication is primarily indicated for the treatment of certain types of breast cancer, particularly those that are HER2-positive, which means they overexpress the human epidermal growth factor receptor 2. Lapatinib works by inhibiting the activity of this receptor, thereby slowing down or stopping the growth of cancer cells. Hertab is often used in combination with other therapies, such as capecitabine, to enhance its effectiveness. The formulation is designed to provide a targeted approach to cancer treatment, making it a vital option for patients battling advanced or metastatic breast cancer. As a targeted therapy, Hertab aims to minimize damage to healthy cells while focusing on cancerous ones, which is a significant advantage over traditional chemotherapy.

Fulzos 250MG Injection (5ml) is a pharmaceutical formulation containing Fulvestrant, a potent estrogen receptor antagonist used primarily in the treatment of hormone receptor-positive breast cancer in postmenopausal women. This medication works by blocking the effects of estrogen, a hormone that can promote the growth of certain types of breast tumors. Fulzos is typically administered via intramuscular injection, allowing for effective absorption and action within the body. The composition of Fulzos includes 250mg of Fulvestrant in a 5ml solution, which is designed to be injected into the muscle, ensuring that the drug is delivered directly into the bloodstream for optimal therapeutic effect. This injection is crucial for patients who have experienced disease progression following anti-estrogen therapy, providing a targeted approach to managing their condition. The use of Fulzos is an essential part of a comprehensive treatment plan for breast cancer, helping to improve patient outcomes and quality of life.

Vetira 100MG Injection (5ml) is a pharmaceutical product that contains Levetiracetam as its active ingredient, delivering a dosage of 100mg per 5ml. This medication is primarily used in the management of epilepsy, particularly for the treatment of partial-onset seizures in adults and children. Levetiracetam works by modulating neurotransmitter release and stabilizing electrical activity in the brain, making it effective in reducing seizure frequency. The injection form of Vetira is particularly beneficial for patients who may have difficulty swallowing pills or require immediate seizure control. It is essential for healthcare providers to assess the patient’s medical history and current medications before initiating treatment with Vetira to ensure its safe and effective use.